ANI Pharmaceuticals Mergers and Acquisitions Summary

Life Science Company

ANI Pharmaceuticals has acquired 13 companies, including 7 in the last 5 years. A total of 1 acquisition came from private equity firms.

ANI Pharmaceuticals’ largest acquisition to date was in 2015, when it acquired Merck - Two NDAs for $75M. ANI Pharmaceuticals has acquired in 5 different US states, and 4 countries. The Company’s most targeted sectors include life science (85%) and medical products (16%).

Join Mergr and gain access to ANI Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity13
    • M&A Buy Activity13
  • Total Sectors Invested 2
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 11
  • M&A Advisors 2

ANI Pharmaceuticals, Inc.

210 Main Street West,
Baudette, Minnesota 56623
United States,
(218) 634-3500
www.anipharmaceuticals.com

ANI Pharmaceuticals, Inc. is a developer, manufacturer, and marketer of top-quality prescription pharmaceuticals. In two facilities with combined manufacturing, packaging, and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder, and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. ANI has several ANDAs pending FDA approval and in various stages of development. ANI Pharmaceuticals was formed in 2001 and is headquartered in Baudette, Minnesota.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (1.2/yr) # 7 1 3 1 1 - 13
vol $100M $14M $53M $166M
Sell (0.0/yr) # - - - - - - 0
  13

Most Recent M&A

Company Date Value Type
Amerigen Pharmaceuticals - Commercial and Pipeline Generic Products 2020-01-09 53M USD Divestiture
Suzhou, China
Coeptis Pharmaceuticals, Inc. - Seven Development Stage Drug Products 2019-06-18 14M USD Divestiture
Wexford, Pennsylvania
WellSpring Pharma Services 2018-08-09 - Add-on Acquisition
Oakville, Ontario · www.wellspringcmo.com
Amneal Pharmaceuticals LLC - Generic Products and Assets 2018-04-27 - Divestiture
Bridgewater, New Jersey
Impax Laboratories, Inc. - Generic Products and Assets 2018-04-27 - Divestiture
Hayward, California
Holmdel Pharmaceuticals LP - InnoPran XL 2017-02-24 - Divestiture
Cranford, New Jersey
Cranford Pharmaceuticals - Inderal LA Assets 2016-03-11 - Divestiture
, United States
Merck - Two NDAs 2015-09-21 75M USD Divestiture
, United States
Teva Pharmaceutical Industries Ltd. - Flecainide Tablets USP 2015-03-05 - Divestiture
, Israel
Noven Therapeutics - NDA Lithobid 2014-07-01 12M USD Divestiture
, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 11 (85%) 114M (68%) - -
Medical Products 2 (15%) 53M (32%) - -
Total 13 $166M - -

By Geo

State/Country Buy Value Sell Value
United States 10 114M - -
  New Jersey 2 - - -
  Minnesota 2 - - -
  Pennsylvania 1 14M - -
  California 1 - - -
Canada 1 - - -
  Ontario 1 - - -
China 1 53M - -
Israel 1 - - -
Domestic 10 (77%) 114M (68%) - -
Cross-border 3 (23%) 53M (32%) - -
Total 13 $166M - -

Top M&A Advisors

Financial Deals
Oppenheimer & Co.
1
Legal Deals
Oppenheimer Wolff & Donnelly LLP
1

Deal Values

buy # Total
< $100M 5 $166M
TOTAL $166M
Largest Merck - Two NDAs
$75M (2015-09-21)

M&A Connections

Deals
Acquired from
Investor(s)
8%
1 (8%)
Strategic(s)
92%
11 (92%)

 Subscribe to unlock this and 159,618
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 148K M&A Transactions
  • 156K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 47K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.